. Several recent studies modeled scRNA-seq bias and uncertainty by fitting a probabilistic model for each gene measurement in each cell, which represents the data in a lower and potentially less noisy dimension [8] [9] [10] . Once these models have been fit, they can be used for various tasks such as clustering 11 , imputation 12 , and differential expression analysis 13 . Although these methods have provided new insights into the biological variation between cells, they assume that a generalized linear model can be used to accurately map onto a low-dimensional manifold underlying the data, which is not necessarily justified. Also, different models are currently used for different tasks, whereas the application of a single distributional model to a range of downstream tasks would help to ensure consistency and interpretability. Finally, most existing methods cannot be applied to more than tens of thousands of cells, but recent datasets include hundreds of thousands of cells or more 14 .
To address these limitations, we developed scVI, a fully probabilistic approach for the normalization and analysis of scRNA-seq data. scVI is based on a hierarchical Bayesian model 15 with conditional distributions specified by deep neural networks, which can be trained very efficiently even for very large datasets. The transcriptome of each cell is encoded through a nonlinear transformation into a low-dimensional latent vector of normal random variables. This latent representation is then decoded by another nonlinear transformation to generate a posterior estimate of the distributional parameters of each gene in each cell. The transformation assumes a zero-inflated negative binomial distribution, which accounts for the observed overdispersion and limited sensitivity 10, 16, 17 .
Several recent papers have also demonstrated the utility of neural networks for embedding scRNA-seq datasets in a scalable manner [18] [19] [20] [21] . scVI stands out from these as the only method that explicitly models the two key nuisance factors in scRNA-seq data (library size 8, 22 and batch effects 10, 23 ) and the only readily available solution for a range of analysis tasks using the same generative model (Methods, Supplementary Note 1, Supplementary Table 1) . To demonstrate its flexibility, we carried out batch removal, normalization, dimensionality reduction, clustering, and differential expression. We show here that for each of these tasks, scVI compared favorably to current state-of-the-art methods.
Results
The scVI model. We modeled the observed expression x ng of each gene g in each cell n as a sample drawn from a zero-inflated negative binomial (ZINB) distribution | ℓ p x z s ( , , ) ng n n n conditioned on the batch annotation s n of each cell (if available), as well as two additional, unobserved random variables 10, 16, 17 (Methods). The first variable, ℓ n , is a one-dimensional Gaussian that represents nuisance variation due to differences in capture efficiency and sequencing depth, and serves as a cell-specific scaling factor. The second variable, z n , is a low-dimensional vector of Gaussians (set here to ten dimensions; Supplementary Fig. 1 ) representing the remaining variation, which should better reflect biological differences between cells 24 . We used it to represent each cell as a point in a low-dimensional latent space that served for visualization and clustering. In the scVI model, a neural network maps the latent variables to the parameters of the ZINB distribution (Fig. 1a , neural networks 5 and 6). This mapping goes through intermediate values ρ g n , which provide a batch-corrected, normalized estimate of the percentage of transcripts in each cell n that originate from each gene g. We used these estimates for differential expression analysis and its scaled version (multiplying ρ g n by the estimated library size ℓ n ) for imputation. We derived an approximation for the posterior distribution of the latent variables ℓ | q z x s ( ,log , ) n n n n by training another neural network using variational inference and a scalable stochastic optimization procedure [25] [26] [27] (Fig. 1a , neural networks 1-4).
Model evaluation.
We evaluated scVI along with a set of benchmark methods for probabilistic modeling and imputation of scRNAseq data using a collection of published datasets spanning a range of technical and biological characteristics (Supplementary Table 2 Deep generative modeling for single-cell transcriptomics and Methods). To assess the scalability of training, we randomly subsampled a dataset of 1.3 million mouse brain cells 28 (BRAIN-LARGE). To facilitate comparison to state-of-the-art algorithms for probabilistic modeling and dimensionality reduction of single-cell data [8] [9] [10] [11] [12] , which may be less scalable, we limited this analysis to the 720 genes with the largest s.d. across all cells (Fig. 1b) . We found that most methods were capable of processing up to 50,000 cells before running out of memory (using 32 GB RAM). In contrast, scVI was generally faster and scaled to 1 million cells, thanks to its reliance on a fixed number of cells at each iteration of iterative stochastic optimization (Methods). We observed similar scalability with DCA 20 , a denoising autoencoder that also uses stochastic optimization. Notably, as the dataset size approached 1 million cells, fewer training iterations (or epochs) were needed, and thus heuristics for stopping the learning process may save time. Indeed, standard scVI, which uses a fixed number of epochs, was slower than DCA, which uses the stopping heuristic by default, but scVI's early-stopping option greatly enhanced its speed (it trains in under 1 h) without affecting data fit ( Supplementary Fig. 2 ).
Next, we evaluated the extent to which the methods fit the data by assessing their ability to accurately impute missing values. recover the values. In most cases, methods based on a ZINB distribution-namely, scVI, DCA, and ZINB-WaVE 10 (when it scales to the dataset size)-performed better than methods that use alternative distributions 8, 12 (e.g., log normal in ZIFA 9 ), thus supporting the suitability of ZINB for current scRNA-seq datasets. In one important exception, scVI was outperformed by MAGIC 12 (which imputes by means of propagation in a cell-cell similarity graph) on the HEMATO hematopoietic differentiation dataset, which includes fewer cells (4,016) than genes (7, 397) . In such cases, scVI is expected to underfit the data, potentially leading to worse imputation accuracy. However, restriction of the analysis to the top 700 variable genes improved imputation ( Supplementary Fig. 3c ).
As an additional evaluation of model fit, we tested the likelihood of data that were held out during training, and obtained results in agreement with those of the synthetic dropout test ( Supplementary  Fig. 7, Supplementary Table 3) . Furthermore, scVI, like ZIFA and factor analysis (FA), can also be used to generate unseen data via sampling of the latent space. As evidence of the validity of this procedure, we sampled from the posterior distribution given the perturbed training data, and observed that the samples were largely consistent with the unperturbed data ( Supplementary Fig. 8 ).
Capturing biological structure in latent space. We next evaluated the extent to which the latent space inferred by scVI reflects biological variability between cells. One way to assess this is to rely on prior stratification of the cells into biologically meaningful subpopulations, which is normally done by unsupervised clustering followed by manual inspection and annotation 29, 30 . We evaluated accuracy with respect to these stratifications (available for the CORTEX and PBMC datasets) by applying k-means clustering on the latent space and testing for overlap with the annotated subpopulations (using the same k as in the annotated data), or by comparing the proximity of cells in the same subpopulation to the proximity of cells from different subpopulations (Methods). A dataset that included single-cell protein measurements in addition to mRNA (CBMC) 33 served as an alternative benchmark, by allowing us to evaluate the extent to which the similarity between cells in the mRNA latent space resembled their similarity at the protein level (Methods).
In these tests, scVI grouped cells that were from the same annotated subpopulation or that expressed similar proteins, and it compared favorably to other methods that aim to infer a biologically meaningful latent space (ZIFA, ZINB-WaVE, DCA, and FA; Supplementary Fig. 9 ). Notably, a simpler version of scVI that does not explicitly model library size did not perform as well as the standard scVI, thus supporting our modeling choice.
Next, we benchmarked scVI with SIMLR 11 , a method that couples clustering with learning of a cell-cell similarity matrix and a respective low-dimensional (latent) representation. SIMLR outperformed scVI by providing a tighter representation of the computationally annotated subpopulations. This result was expected, as SIMLR explicitly aims to produce a tight representation in a target number of clusters; however, a possible consequence of this action is that SIMLR may not capture higher-resolution structural properties of the cell-cell similarity map. Indeed, in the protein-versusmRNA test, scVI and DCA performed best, albeit by a small margin ( Supplementary Fig. 9c ). scVI also more accurately captured hierarchical structure among cell subsets, such as was reported for cortical cells (CORTEX); 29 cells from related subpopulations tended to be closer to each other in scVI's latent space ( Supplementary  Fig. 9e-g ). Another important case is when variation is continuous rather than discrete, as reported for differentiating hematopoietic cells (HEMATO) 32 . SIMLR identified several discrete clusters and did not reflect the continuous nature of this system as well as scVI or PCA did (Fig. 2, Supplementary Fig. 10 ). Finally, the data may be almost entirely dominated by noise and lack structure. On a noisy dataset that we generated by sampling at random from a vector of ZINB distributions, SIMLR erroneously reported 11 distinct clusters, which were not perceived by other methods ( Supplementary  Fig. 11 ). Altogether, these results suggest that the latent space of scVI is flexible and describes the data well, even when the data do not fit in a simple structure of discrete cell states.
Accounting for technical variability. scVI provides a parametric distribution designed to decouple biological signal from the effects of sample-level categorical nuisance factors such as batch annotations and variation in sequencing depth. To evaluate the capacity of scVI to correct batch effects, we used a mouse retinal bipolar neuron dataset consisting of two batches (RETINA). We defined an entropy measure to evaluate the mixing of cells from different batches in any local neighborhood of the latent space (abstracted using a k-nearest-neighbor graph; Methods). In this dataset, scVI aligned the batches considerably better than ComBat 34 (which uses linear models and empirical Bayes shrinkage) and a recent method based on matching of mutual nearest neighbors 35 , while still maintaining a tight representation of preannotated subpopulations (Fig. 2,  Supplementary Figs. 9d and 12 ). Algorithms that do not account for batch effects in their models provided poor mixing of batches, as expected. Specifically, although SIMLR and DCA were capable of clustering the cells well within each batch, the respective clusters from each batch remained largely separated. We obtained similar results when we applied a simplified version of scVI with no batch variable, thus supporting our modeling choice.
Turning to confounding due to variation in sequencing depth, we found, as expected, that in relatively homogeneous populations the library size factor inferred by scVI (ℓ n ) strongly correlated with the observed depth per cell (for example, in a subpopulation of peripheral blood mononuclear cells (PBMCs); Supplementary  Fig. 13a) . A related technical issue is low sensitivity due to limited mRNA capture efficiency and (to a lesser extent) sequencing depth, which exacerbates the number of zero entries and can distort similarity among homogeneous cells. We found that most zero entries could be explained by the negative binomial component ( Supplementary Fig. 14a,b ) rather than the 'inflation' of additional unexplained Bernoulli-distributed zeros. Consistently, the occurrence of zero entries largely agreed with a process of random sampling of genes from each cell, in a manner proportional to their expected frequency (as inferred in the matrix ρ of our model, which is proportional to the negative binomial mean) and with no additional bias ( Supplementary Fig. 13b and Supplementary Note 2). Indeed, we found that zero probabilities from the negative binomial distribution correlated more with cell-specific quality factors related to library size (e.g., number of reads per unique molecular identifier), whereas zero probabilities from the Bernoulli correlated more with quality factors indicative of alignment errors (using subpopulations of BRAIN-SMALL cortical cells or PBMCs; Supplementary  Figs. 13c,d and 14c,d ), possibly because of contamination or mRNA degradation. Taken together, these results corroborate the idea that most zeros, at least in the datasets explored here, can be explained by low (or zero) 'biological' abundance of the respective transcript, exacerbated by limited sampling.
Differential expression.
With its probabilistic representation of the data, scVI provides a natural way of performing various types of hypothesis testing, while intrinsically controlling for nuisance factors. In the case of differential expression between two sets of cells, one can use the model to approximate the posterior probability of the alternative hypotheses (genes are different) and that of the null hypotheses through repeated sampling from the variational distribution, thus obtaining a low variance estimate of their ratio (i.e., Bayes factor 36, 37 ; Methods). To evaluate scVI in comparison with other differential expression methods 13, 17, 20, 38 , we used a dataset of 12,039 PBMCs from a healthy human donor (PBMC) and undertook comparisons between B cell and dendritic cell clusters, and between CD4 + and CD8 + T cell clusters. Bulk-level comparative analysis of similar cell subsets served as a gold standard 39, 40 . For evaluation, we first defined genes as true positives (Benjamini-Hochberg (BH)-adjusted P value < 0.05 in bulk data) and then calculated the area under the receiver operating characteristic curve (AUROC) on the basis of the Bayes factor for scVI or BH-corrected P value for the other methods. Because the definition of true positives requires a somewhat arbitrary threshold, we also used a second score that evaluated the reproducibility of gene ranking (bulk reference versus single cell, considering all genes), using the irreproducible discovery rate (IDR) 41 . scVI had the highest AUROC in the T cell comparison, whereas edgeR outperformed scVI by a smaller margin in the comparison of B cells versus dendritic cells. scVI performed best with respect to IDR in both comparisons (Fig. 3, Supplementary Fig. 15a-e) . We noted that the use of DCA followed by DESeq2 constituted a solid improvement over the direct application of DESeq2, which was designed for bulk data, thus supporting the need for single-cell-adapted models. Furthermore, a simpler variant of scVI that does not include the library size factor performed extremely poorly in the comparison of B cells versus dendritic cells, thus supporting the usefulness of explicit inclusion of library size normalization in the model.
Discussion
scVI was designed to address an important need in the rapidly evolving field of single-cell transcriptomics-namely, to account for measurement uncertainty and bias in tertiary analysis tasks through a common, scalable statistical model. As a result, it provides a computationally efficient and 'all-inclusive' tool that couples lowdimensional probabilistic representation of gene expression data with downstream analysis capabilities, comparing favorably to stateof-the-art methods in each of a range of tasks, including batch-effect correction, imputation, clustering, and differential expression.
scVI takes raw count data as input and includes an effective normalization procedure that is integrated into its model. First, it learns a cell-specific scaling factor as a hidden variable, with the objective of maximizing the likelihood of the data 8, 10, 22 , which is more justifiable than a posteriori correction of the observed counts 5 . Second, scVI explicitly accounts for batch annotations, via a mild assumption of conditional independence. We demonstrated that both of these components are essential for the method's performance.
The scVI deep learning architecture is built on several canonical building blocks such as nonlinearities, regularization, and meanfield approximation to the posterior 25 (Methods). The exploration of other, possibly better, architectures 42 and procedures for parameter and hyperparameter tuning 43 might in some instances provide a better model fit and more suitable approximate inference. Notably, because our procedure has a random component and optimizes a nonconvex objective function, it might give alternative results with different initializations. To address this, we demonstrated the stability of scVI in terms of its objective function, as well as imputation and clustering (Supplementary Fig. 1) . A related issue is that if there are few observations (cells) for each gene, the prior and the inductive bias of the neural network might keep scVI from fitting the data closely. Indeed, gene prefiltering may be warranted in cases where there are fewer cells than genes. A complementary approach would make use of techniques such as Bayesian shrinkage 17 or regularization and second-order optimization 10 . However, we were able to show that for a range of datasets of varying sizes, scVI fit the data well and captured relevant biological diversity between cells.
Because it provides a general probabilistic representation of gene expression, scVI could enable other forms of scRNA-seq analysis not explored in this study, such as lineage inference 1 and cell-state annotation 7, 44 . Furthermore, because it requires only the latent space and the model specification (which both have a low memory footprint) to generate any data point (cell × gene) of interest, scVI can be used as an effective baseline for scalable and interactive visualization tools [45] [46] [47] . Finally, scVI can be extended to merge multiple datasets from a given tissue while integrating prior biological annotations of cell types. We therefore expect this work to be of immediate interest, especially where dataset harmonization needs to be scalable and conducive to various forms of downstream analysis 14 .
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Methods
The scVI probabilistic model. First, we present in more detail the generative process for scVI. Each expression value x ng is drawn independently through the following process: A standard multivariate normal prior for z is commonly used in variational autoencoders because it can be reparameterized in a differentiable way into any arbitrary multivariate Gaussian random variable 25 , which turns out to be extremely convenient in the inference process.
B denotes the number of batches and R ℓ ℓ ∈ μ σ + , B parameterize the prior for the scaling factor (on a log scale). ℓ ℓ μ σ , are set to be the empirical mean and variance of the log-library size per batch. We note that the random variable ℓ n is not the log-library size (scaling the sampled observation) itself but a scaling factor that is expected to correlate strongly with log-library size (hence the choice of the parameters). The parameter R θ ∈ + G denotes a gene-specific inverse dispersion, estimated via variational Bayesian inference.
f w and f h are neural networks that map the latent space and batch annotation back to the full dimension of all genes:
G . We use superscript annotation (for example, f z s ( , ) w g n n ) to refer to a single entry that corresponds to a specific gene g. Neural network f w is constrained during the inference to encode the mean proportion of transcripts expressed across all genes by the use of a softmax activation at the last layer. Namely, for each cell n, the sum of f z s ( , )
values over all genes g is 1. Neural network f h encodes whether a particular entry has dropped out owing to technical effects 9, 10 . These intermediate vectors can therefore be interpreted as expected frequencies. Importantly, we note that neural networks allow users to go beyond the generalized linear model framework and provide a more flexible model of gene expression. All neural networks use dropout regularization and batch normalization. Each network has one, two, or three fully connected layers, with 128 or 256 nodes each. Details are provided in Supplementary Table 2 . The activation functions between two hidden layers are all ReLU. We use a standard link function to parameterize the distribution parameters (exponential, logarithmic, or softmax). Weights for some layers are shared between f w and f h . and reducing the dimensionality of the data by using a variational autoencoder with a Gaussian prior and a Gaussian conditional probability.
One way to enhance a model is to change the Gaussian conditional probability to one of the many available count distributions, such as ZINB, negative binomial (NB), Poisson, and others. Recent work by Eraslan et al. using simulated data shows that when the dropout effect drives the signal-to-noise ratio to a less favorable regime, a denoising autoencoder with mean squared error (i.e., Gaussian conditional likelihood) cannot recover cell types from expression data, whereas an autoencoder with ZINB conditional likelihood can 20 . This result points to the importance of at least modeling the sparsity of the data and is in agreement with previous contributions 9, 10 . The next question is which count distribution to use. In scVI we have chosen to use the ZINB, a choice motivated by published literature (for example, ref. 10 ). First, the choice of negative binomial is common with RNA-seq data, as they are overdispersed 17 . Furthermore, under some assumptions this distribution captures the steady-state form of the canonical two-state promoter-activation model 16 . Finally, recent work by Grønbech et al 21 .
proposes an analysis based on Bayesian model selection (held-out log-likelihood as in this paper). In that analysis, the NB and ZINB distributions stand out with similarly high scores. We demonstrate that the addition of a zero-inflation (Bernoulli) component is important for explaining a subset of the zero values in the data (Supplementary Fig. 14) and that it captures important aspects of technical variability that are not captured by the NB component (Supplementary Fig. 13) .
To enhance the model further, we added terms to account for library size as a nuisance factor, which can be considered as a Bayesian approach to normalization as in refs 8, 22 . We showed how this contributes to our model by increasing clustering scores and differential expression analysis accuracy on the PBMC dataset.
As a further enhancement, we designed the generative model to explain data from different experimental batches. This is not a trivial task, as a substantial covariate shift may exist between the observed transcript measurements. We showed how this modification to our model is crucial when dealing with batch effects in subsection on the RETINA dataset.
Datasets and preprocessing.
Below we describe all of the datasets and the preprocessing steps used in the current work. We focused on relatively large datasets (3,000 cells or more) with unique molecular identifiers, thus providing enough information during training and avoiding the problem of overcounting due to amplification. An asterisk after the dataset name indicates that we used it as an auxiliary dataset; these datasets were used not for general benchmarking but rather to support specific points presented in the paper. The only case where we subsampled the data multiple times was that of the BRAIN-LARGE dataset. However, we simply used one instance of it to report all possible scores (further details are presented in Supplementary Table 2) .
CORTEX. The Mouse Cortex Cells dataset from ref. 29 contains 3,005 mouse cortex cells and gold-standard labels for seven distinct cell types. Each cell type corresponds to a cluster to recover (Supplementary Table 4 ). We retained the top 558 genes ordered by variance as in ref. 8 .
PBMC.
We considered scRNA-seq data from two batches of PBMCs from a healthy donor (4,000 and 8,000 PBMCs, respectively) 30 . We derived quality control metrics using the cellrangerRkit R package (v. 1.1.0). Quality metrics were extracted from Cell Ranger throughout the molecule-specific information file. After filtering as in ref. 23 , we extracted 12,039 cells with 10,310 sampled genes and generated biologically meaningful clusters with the software Seurat (Supplementary Table 5 ). We then filtered genes that we could not match with the bulk data used for differential expression, which resulted in g = 3,346.
BRAIN-LARGE.
This dataset contains 1.3 million brain cells from 10x Genomics 28 . We randomly shuffled the data to get a subset of 1 million cells and ordered genes by variance to retain first 10,000 and then 720 sampled variable genes. This dataset was then sampled multiple times in cells for the runtime and goodness-of-fit analysis. We report imputation scores for the 10,000 cells and 720 gene samples only.
RETINA.
After filtering according to the original pipeline, the dataset of bipolar cells from ref. 31 contained 27,499 cells and 13,166 genes from two batches. We used the cluster annotation from 15 cell types from the author. We also extracted their normalized data with ComBat and used it for benchmarking.
HEMATO. This dataset with continuous gene expression variations from hematopoietic progenitor cells 32 contains 4,016 cells and 7,397 genes. We removed the library basal-bm1, which was of poor quality, on the basis of the authors' recommendation. We used their population balance analysis result as a potential function for differentiation. CBMC*. This dataset includes 8,617 cord blood mononuclear cells 33 profiled using 10 × , along with 13 well-characterized mononuclear antibodies for each cell. We kept the top 600 genes by variance.
BRAIN-SMALL*. This dataset, which consists of 9,128 mouse brain cells profiled using 10x 28 , was used as a complement to PBMC for our study of zero abundance and quality control metric correlation with our generative posterior parameters. We derived quality control metrics by using the cellrangerRkit R package (v. 1.1.0). Quality metrics were extracted from Cell Ranger throughout the molecule-specific information file. We kept the top 3,000 genes by variance. We used the clusters provided by Cell Ranger for the correlation analysis of zero probabilities.
Statistics. Differential expression for bulk datasets. Specifically, we assembled a set of genes that are differentially expressed between human B cells and dendritic cells (microarrays; n = 10 in each group 39 ; GSE29618) and between CD4
+ and CD8 + T cells (microarrays; n = 12 in each group 40 ; GSE8835). For GSE29618, we first loaded bulk human expression array data using the GEOquery package, selecting all B cell and myeloid dendritic cell samples from the baseline ("Day0") time point. We retained all expression features described by exactly one gene symbol and regressed the expression of these expression measures on cell-type covariate (B cell versus myeloid dendritic cell) using lmFit linear modeling in limma. P values were derived from empirical Bayes moderated t-tests for differences between the two cell types, using eBayes in limma. We conducted an identical study on GSE8835 for the CD4 + and CD8 + T cell comparison. These P values were then corrected via the standard BH procedure.
Differential expression for scRNA-seq datasets. We used the packages as detailed above. The P values were then corrected via the standard BH procedure.
Capturing technical variability.
We computed the average probability of zero from the NB distribution and from the Bernoulli across all genes for a particular cell. We tested for a correlation between these cell-specific zero probabilities and cell-specific quality control metrics by using a Pearson-correlation test.
Evaluation. We describe below how we computed the metrics used in the study. Further details of the algorithms used for benchmarking in this work are provided in Supplementary Note 5.
Log-likelihood on held-out data. We provide a multivariate metric of goodness of fit on the data in Supplementary Note 6.
Corrupting the datasets for imputation benchmarking. In this study we used two different approaches to measure the robustness of algorithms to noise in the data:
• Uniform zero introduction: we randomly selected 10% of the nonzero entries and multiplied the entry n with a Ber(0.9) random variable.
• Binomial data corruption: we randomly selected 10% of the matrix and replaced an entry n with a Bin(n, 0.2) random variable.
Accuracy of imputing missing data. As imputation is tantamount to replacing missing data by its mean conditioned on being observed, we used the median L 1 distance between the original dataset and the imputed values for corrupted entries only. For MAGIC, we used the output of the associated software. For BISCUIT, we used the imputed counts. For ZIFA, we used the mean of the generative distribution conditioned on the nonzero event (mean of the factor analysis part) that we projected back into count space. For scVI and ZINB-WaVE, we used the mean of the NB distribution.
Silhouette width. The silhouette width requires either a similarity matrix or a latent space. We can define a silhouette score for each sample i with
where a(i) is the average distance from i to all data points in the same cluster c i , and b(i) is the lowest average distance from i to all data points in the same cluster c among all clusters c. Clusters can be replaced with batches if one is estimating the silhouette width to assess batch effects 23 .
Clustering metrics. The following metrics require clustering and not simply a similarity matrix. For these, we use k-means clustering on the given latent space of dimension 10 with T = 200 random initializations to achieve a stable score.
Adjusted Rand index. This index requires clustering. For most indexes, 
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